SP
Starpharma Holdings Limited
SPHRY · OTC
$5.22 -0.38% (-$0.02)
1M +7.41%
Market Cap $308.8M
P/E Ratio -
Div. Yield 1.29%
ROE 37.73%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 22.42x
P/S 26.20x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 26.58%
Rev. growth 39.49%
FCF growth N/A
Profitability
20 /100
Weak Net margin 61.95%
Op. margin 159.60%
FCF margin 29.67%
Quality
8 /100
Poor ROE 37.73%
ROA 38.39%
Asset turnover 0.62x
Debt
100 /100
Low Current ratio 3.40x
Debt/Equity 0.05x
Net debt/EBITDA N/A
Stability
43 /100
Moderate Rev. volatility 72.71%
EPS volatility 34.85%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o SPHRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheryl Maley
Employees
50
Headquarters
Abbotsford
Nadchodzące wydarzenia
02 MAR
Earnings
Upcoming earnings report